SIRT3 and metabolic dysfunction-associated steatotic liver disease: SIRT3, a sirtuin highly expressed in the liver of mice, has been shown to enhance mitochondrial activity and ameliorate NAFLD by modulating ketogenesis, β-oxidation, mitogenesis, and antioxidant response systems (Nassir et al., 2018).